The New Subcutaneous (SC) Landscape: Adapting Drug Delivery for Biologics Administration at Home

The rise of biologics is driving a massive shift: sensitive therapeutics are moving from clinic visits to Subcutaneous (SC) self-administration at home. This empowers patients and supports decentralized healthcare. Join Datwyler to explore how this trend is modifying the landscape of SC drug delivery. Learn what your system needs to succeed in the era of patient-centric care.

Register Free: https://www.pharmtech.com/pt_w/sc_landscapes

Event Overview:

The pharmaceutical industry is experiencing a profound transformation as high-value, sensitive biologics transition from requiring in-clinic intravenous (IV) infusion to convenient, at-home subcutaneous (SC) self-administration. Join Datwyler experts to analyze the forces reshaping the SC drug delivery market. Learn about critical system changes covering viscosity, volume limitations, and the role of optimized components in ensuring drug stability and patient safety.

Key Learning Objectives:

1. Ensure drug safety: Learn how component selection is crucial for maintaining drug stability and minimizing risk
2. Analyze the market drivers leading to the shift of biologics and sensitive therapeutics toward decentralized, home-based subcutaneous (SC) self-administration
3. Discover the advantage to coengineering and how an integrated partnership model transforms complex drug delivery challenges into scalable, system-level solutions for the global market

Who Should Attend:

• Quality/regulatory personnel in parenteral drug delivery
• Formulation scientists and packaging engineers
• Device development engineers and managers
• Technical roles involving drug delivery systems
• Experts on extractables and leachables
• Procurement professionals

Speaker:

Paolo Ferrigno
Product Manager prefilled syringes and cartridges
Datwyler Healthcare

In the industry of primary parenteral packaging since 2017, Paolo Ferrigno is the product manager for prefilled syringes and cartridge components at Datwyler Healthcare. At Datwyler, Ferrigno has covered different commercial and technical roles before landing back in product management in 2022. Educated in electronics and later in marketing, Ferrigno has had a wide range of experiences spanning R&D for audio/electronics in the automotive and consumer markets and product management for B2B distribution of industrial and electronics components.

Register Free: https://www.pharmtech.com/pt_w/sc_landscapes